Early Access — free while we kick the tires
EdgarHawk

Seely Lynn

President and CEO

Director Officer
1 filing analyzed · 1 company · Latest 2025-03-18

Never miss a filing from Seely Lynn

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Lyell Immunopharma, Inc. LYEL 1 0 Net buying

Activity

March 2025
high
Buy
175,000 shares
$106,190
Significance 7/10

LYEL CEO Lynn bought 175.0K shares at $0.61 amid cluster buy; stock down -83.9% from 52-week high at $60.20.

Seely Lynn, President and CEO, purchased 175,000 shares at $0.61 on 2025-03-14, increasing holdings by 32.6% to 712,500 shares. This transaction occurs within a broader cluster pattern: 2 other insiders also bought within the past 14 days. Notably, the company is unprofitable, with net income of $-44,583,000.00 in its most recent full fiscal year and quarterly revenue of only $34,000.00, alongside an annual revenue decline of -53.1%. The stock trades at $9.67, down -83.9% from its 52-week high of $60.20 and down -20.8% over the past 30 days. This purchase by the CEO, combined with concurrent insider accumulation, occurs at a severe markdown from recent highs and against a backdrop of severe financial deterioration and losses.

Related insiders